Enterprise Solutions Webinars
-
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
8/16/2023
Since we last spoke in the Spring of 2021, Nevan Charles Elam, JD has managed to advance both of small-but-mighty Rezolute Bio's candidates onto the next phases of their journey. This year, on the back of a $130 million investment, Rezolute Bio is prepping its RZ358 candidate, a monoclonal antibody for congenital hyperinsulinism, for a pivotal phase 3 trial. On this week's episode of the Business of Biotech, we're settling in for an interrogation of Elam on the management principles of maintaining multi-candidate clinical momentum among highly disparate candidates and raising big dollars as a small biotech.
-
Continuous Growth In Advanced Therapies
8/15/2023
As the industry continues to see innovation in manufacturing approaches, the Project Farma team discusses how advanced therapies differ from traditional medicines.
-
How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing
7/26/2023
To enable the development of next-generation lipid-based drug delivery systems, expertise and manufacturing capabilities are critical.
-
Streamlining Viral Vector Development And Gene Therapy Manufacturing
7/19/2023
Explore solutions for gene therapy production from experts, as they highlight the key features of a GMP manufacturing facility, including its technologies and infrastructure, through a virtual tour.
-
Overcoming Development And Manufacturing Challenges
7/13/2023
Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, discusses the importance of maintaining relationships throughout the project timeline as well as how to move to the standardization approach.
-
Biotech Banter: The Realities Of Manufacturing
7/13/2023
Experts discuss automated processes, “platformization,” moving early-stage companies into a commercialization structure, and how the industry can support the academics developing these processes.
-
Supply Chain Challenges For Cell & Gene
7/13/2023
Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, discusses how reducing the CGT supply chain complexity and introducing automation will help to benefit patients and the industry as a whole.
-
Cell And Gene Therapy Analytical Services
7/13/2023
Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, reviews how comprehensive analytical services that cover a wide range of project needs can help keep a project on track.
-
Benefits Of Standardizing Viral Vector Processes
7/13/2023
Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, shares insight into how the standardization process can help reduce project timelines and overall costs on the path to market.
-
The Future of Cell & Gene
7/13/2023
Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, shares how partnering with the right CDMO is essential to gain access to manufacturing platforms that reduce cost and accelerate timelines.